Table 2 Clinical results
SOA Group (n = 101) | OFA Group (n = 101) | Z/χ2 Value | P-value | |
|---|---|---|---|---|
Frequency of vasoactive drugs | 19.623 | 0.001 | ||
0 | 44 (43.6) | 70 (69.3) | ||
1 | 36 (35.6) | 24 (23.8) | ||
2 | 18 (17.8) | 4 (3.9) | ||
3 | 3 (3.0) | 2 (2.0) | ||
4 | 0 (0.0) | 1 (1.0) | ||
Intraoperative infusion volume (mL) | 1000 [1000;1500] | 1000 [1000;1000] | 3.353 | 0.001 |
24-h morphine PCIA use (mg) | 3.6 [0.6;23] | 1.8 [0;4.8] | 3.537 | < 0.001 |
VAS score on D1 | ||||
VAS (at rest) | 1 [0;2] | 1 [0;1] | 0.325 | 0.745 |
VAS (at activity) | 3 [2;4] | 3 [2;3] | 0.264 | 0.792 |
Frequence of nausea and vomit | 0.205 | 0.651 | ||
0 | 99(98.0) | 98(97.0) | ||
1 | 2(2.0) | 3(3.0) | ||
Intraoperative opioid dosage | ||||
Remifentanila | 81.6 ± 28.38 µg | |||
Sufentanil | 23.2 ± 8.85 µg |